ameliamartin
2 posts
Jan 28, 2026
2:26 AM
|
Recent research is bringing new options for narcolepsy beyond classic stimulants. One of the most promising is orexin receptor agonists like oveporexton (TAK?861), designed to restore the brain’s orexin signaling and treat type?1 narcolepsy at its root rather than just symptoms; it’s shown positive Phase?III results and may reach approval soon. Traditional options such as Waklert 150 remain important for daytime alertness under a doctor's guidance.
|
